Research

Text Size:
A
A
A

Clinical Trials

The physicians of VRS are committed to advancing the treatment of vitreoretinal disorders. Our practice has been, and continues to be, an active participant in local and national clinical research studies working on the leading causes of retina-related vision loss.

Current enrolling trials

HARBOR - Sponsored by Genentech- Investigating the treatment of wet macular degeneration with either Lucentis or high dose Lucentis for patients not previously treated for wet macular degeneration in the study eye.

Trials closed to enrollment - in follow up:

CATT - Comparison of wet macular degeneration treatment trials. 2 Year trial, comparing Avastin and Lucentis for patients with wet macular degeneration.

Past Clinical Trials that VitreoRetinal Surgery has participated in:

Drug Therapy for Retinal Vein Occlusions (Anti VEGF, Steroids)
Drug Therapy for Macular Degeneration (Anti VEGF) RNA inhibitor, VEGF trap
Drug Therapy for Macular Edema (Anti VEGF, Steroids)
New Applications for PhotoDynamic Laser -- combination therapy or triple therapy
Subretinal Surgery Trial for AMD
Prophylactic Treatment of AMD
Retinopathy of Prematurity Studies
Transpupillary Thermotherapy in Choroidal Melanoma
Endophthalmitis Vitrectomy Study
Retinal Detachment/Silicone Oil Study
Multidose Safety Study of Gancyclovir Implants in Patients with CMV Retinitis
Safety Study of Intravitreal Fomivirsen in Aids Patients with CMV Retinitis
Diabetes Control & Complications Trial
Diabetic Retinopathy Study
Early Treatment Diabetic Retinopathy Study
Diabetic Retinopathy/Nephropathy Study

Please contact our Research Department with any questions.

Neal (noestreich@vrssurgery.com) or Julie (jenloe@vrssurgery.com)